» Articles » PMID: 35600433

Investigation of Effective Natural Inhibitors for Starch Hydrolysing Enzymes from Simaroubaceae Plants by Molecular Docking Analysis and Comparison with Studies

Overview
Journal Heliyon
Specialty Social Sciences
Date 2022 May 23
PMID 35600433
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aims to find the effective natural enzyme inhibitors against alpha-amylase and alpha-glucosidase from the array of compounds identified in plants of the Simaroubaceae family using molecular docking and ADME/Toxicity studies. Among the 218 compounds docked against seven enzymes, buddlenol-A and citrusin-B showed the best binding energies (kcal/mol) of -7.830 and -7.383 against human salivary alpha-amylase and pancreatic alpha-amylase respectively. The other two compounds 9-hydroxycanthin-6-one and bruceolline-B had the best binding energy of -6.461 and -7.576 against N-terminal and C-terminal maltase glucoamylase respectively. Whereas the binding energy of prosopine (-6.499) and fisetinidol (-7.575) was considered as the best against N-terminal and C-terminal sucrase-isomaltase respectively. Picrasidine-X showed the best binding energy (-7.592) against yeast alpha-glucosidase. The study revealed that the seven compounds which showed the best binding energy against respective enzymes are considered as the 'lead hit compounds'. Even though the 'lead hit compounds' are not obeying all the laws of ADMET, the drug-likeness properties of 9-hydroxycanthin-6-one, fisetinidol, picrasidine-X, and prosopine were considerable. Also, kaempferol-3-O-pentoside was the recent compound identified from the plant extract found to be one among the top five lead hit compounds against four enzymes. This study provides valuable insight into the direction of developing natural compounds as potential starch hydrolysing enzyme inhibitors for managing type 2 diabetes.

Citing Articles

Site-directed modification of multifunctional lignocellulose-degrading enzymes of straw based on homologous modeling.

Wang Z, Zhou M, Cao N, Wang X World J Microbiol Biotechnol. 2023; 39(8):214.

PMID: 37256388 DOI: 10.1007/s11274-023-03663-8.


Effect of Hot- and Cold-Water Treatment on Broccoli Bioactive Compounds, Oxidative Stress Parameters and Biological Effects of Their Extracts.

Sola I, Davosir D, Kokic E, Zekirovski J Plants (Basel). 2023; 12(5).

PMID: 36903996 PMC: 10005114. DOI: 10.3390/plants12051135.


subsp. alenda (Ephedraceae) leaf extracts: phytochemical screening, anti-diabetic, anti-obesity and anti-toxic activities on diabetic-induced liver-kidney-testes toxicities and inhibition of α-amylase and lipase enzymes.

Saidi S, Al-Shaikh T, Alghamdi O, Hamden K Heliyon. 2022; 8(12):e11954.

PMID: 36478797 PMC: 9720601. DOI: 10.1016/j.heliyon.2022.e11954.

References
1.
Baell J, Holloway G . New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010; 53(7):2719-40. DOI: 10.1021/jm901137j. View

2.
Aamir M, Singh V, Dubey M, Meena M, Kashyap S, Katari S . Prediction, Characterization, Molecular Docking, and Dynamic Studies on Fungal SDRs as Novel Targets for Searching Potential Fungicides Against Fusarium Wilt in Tomato. Front Pharmacol. 2018; 9:1038. PMC: 6204350. DOI: 10.3389/fphar.2018.01038. View

3.
Ikarashi N, Toda T, Okaniwa T, Ito K, Ochiai W, Sugiyama K . Anti-Obesity and Anti-Diabetic Effects of Acacia Polyphenol in Obese Diabetic KKAy Mice Fed High-Fat Diet. Evid Based Complement Alternat Med. 2011; 2011:952031. PMC: 3137845. DOI: 10.1093/ecam/nep241. View

4.
Huang S, Strong J, Zhang L, Reynolds K, Nallani S, Temple R . New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol. 2008; 48(6):662-70. DOI: 10.1177/0091270007312153. View

5.
de Souza G, De-Oliveira A, Soares V, Chagas L, Barbi N, Paumgartten F . Chemical profile, liver protective effects and analgesic properties of a Solanum paniculatum leaf extract. Biomed Pharmacother. 2018; 110:129-138. DOI: 10.1016/j.biopha.2018.11.036. View